Press Releases

On January 1, 2021, the Berlin Institute of Health (BIH ) will become the translational research unit of Charité – Universitätsmedizin Berlin and will then form – alongside the hospital and the medical faculty – Charité’s third pillar.

Berlin will become one of four new National Center for Tumor Diseases (NCT) locations in addition to Heidelberg and Dresden. This was announced today by the Federal Ministry of Education and Research, recognizing the outstanding achievements of Charité, the BIH and the MDC in advancing cancer treatment and research.

Research groups from Charité – Universitätsmedizin Berlin and the Max Delbrück Center for Molecular Medicine (MDC) are joining forces with other Berlin-based partners. Pooling their experience and outstanding expertise in the field of mass spectrometry, they will form a new ‘Forschungskern’ or ‘research core’.

Some 27 young researchers have been selected for the prestigious EMBO Young Investigators Programme. Among this year’s awardees is Philipp Junker, a systems biologist at the MDC’s Berlin Institute for Medical Systems Biology.

The MDC is committed to maintaining respectful interactions at the research center and is taking decisive action to prevent and address bullying, discrimination, and sexual harassment. Since early 2019 an Anti-Harassment Task Force, consisting of a broad cross-section of stakeholders, has been preparing guidelines for this very purpose. The Board of Directors has declared its support for the proposed guidelines.

The equivalent of almost 28 times around the equator – this was the distance covered by participants in the cycling competition “Wer radelt am meisten?” (Who cycles the most?). Berlin’s senator for sport announced the winners at a ceremony on Wednesday at the Olympiastadion. The Buch campus took first place in the category “Best Company.”

As Karl Max Einhäupl steps down as Chairman of the Charité’s Executive Board, Thomas Sommer, interim Scientific Director of the MDC, honors Einhäupl’s achievements and applauds him for the excellent and equitable collaboration. Sommer wishes the Charité’s new head, Heyo Kroemer, the very best and much success in his new position.

The administrative agreement is signed, the Berlin Institute of Health (BIH ) will become the third pillar of the Charité. "We are excited about the privileged partnership," says Professor Thomas Sommer, interim Scientific Director of the MDC.

The MDC welcomes the agreement reached between the State of Berlin and the federal government regarding the future of the Berlin Institute of Health (BIH ). The term “privileged partnership” has to now be filled with life and backed up with funding.